SCHEMBL9997372

SCHEMBL9997372

CC(=O)OCC=Cc1cccc(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 7/20 0.49
ALOX5 P09917 2/20 0.45
PTGS1 P23219 2/20 0.45
PTGS2 P35354 2/20 0.45
MAOA P21397 2/20 0.45
MAOB P27338 2/20 0.45
RELA Q04206 1/20 0.44
FBP1 P09467 1/20 0.44
LMNA P02545 1/20 0.44
MMP1 P03956 2/20 0.42
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
MMP12 P39900 1/20 0.42
NPC1 O15118 1/20 0.41
HSP90AA1 P07900 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALOX5AP P20292 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752491 1.00 CACNA1B (0.49) CACNA1BALOX5PTGS1PTGS2MAOA
SCHEMBL28475356 0.89 CACNA1B (0.50) CACNA1BALOX5PTGS1PTGS2MAOA
SCHEMBL28475360 0.88 CACNA1B (0.52) CACNA1BALOX5PTGS1PTGS2MAOA
SCHEMBL27628628 0.86 LCK (0.49) MAOAMAOBFBP1MMP1MMP2
SCHEMBL28462136 0.85 CACNA1B (0.47) CACNA1BALOX5PTGS1PTGS2MAOA
SCHEMBL21100072 0.83 CYP4F2 (0.42) CACNA1BALOX5PTGS1PTGS2MAOA
SCHEMBL9998507 0.83 NFE2L2 (0.50) CACNA1BPTGS1PTGS2MAOAMAOB
SCHEMBL9997657 0.83 CYP1A2 (0.53) CACNA1BMAOAMAOBRELAMMP1
SCHEMBL9997659 0.83 CYP1A2 (0.53) CACNA1BMAOAMAOBRELAMMP1
SCHEMBL9998506 0.83 NFE2L2 (0.50) CACNA1BPTGS1PTGS2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CACNA1B 1372/4885ALOX5 1154/4885PTGS1 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.